Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion.
暂无分享,去创建一个
[1] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[2] E. Braunwald,et al. Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. , 1985, The American journal of cardiology.
[3] Reimer Ka,et al. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. , 1984 .
[4] B E Sobel,et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. , 1984, Circulation.
[5] E. Braunwald,et al. Preservation of high-energy phosphates by verapamil in reperfused myocardium. , 1984, Circulation.
[6] E. Braunwald,et al. Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (1). , 1984, The New England journal of medicine.
[7] R. Kloner,et al. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. , 1984, Circulation.
[8] A. Ross,et al. A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. , 1984, The American journal of cardiology.
[9] J L Ritchie,et al. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. , 1983, The New England journal of medicine.
[10] E. Braunwald,et al. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. , 1983, Circulation.
[11] I. Palacios,et al. Coronary reocclusion after selective administration of streptokinase. , 1983, Circulation.
[12] W. O’Neill,et al. Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. , 1983, The New England journal of medicine.
[13] P. R. Frederick,et al. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. , 1983, The New England journal of medicine.
[14] E. Braunwald,et al. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. , 1983, Journal of the American College of Cardiology.
[15] A. DeMaria,et al. Importance of follow-up medical and surgical approaches to prevent reinfarction, reocclusion, and recurrent angina following intracoronary thrombolysis with streptokinase in acute myocardial infarction. , 1982, American heart journal.
[16] M. Fishbein,et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.
[17] Y. Ikeda,et al. Inhibition of Human Platelet Functions by Verapamil , 1981, Thrombosis and Haemostasis.
[18] R. Jennings,et al. Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. , 1981, Journal of molecular and cellular cardiology.
[19] W. Boden,et al. The Effect of Verapamil on Mechanical Performance of Acutely Ischemic and Reperfused Myocardium in the Conscious Dog , 1981, Circulation research.
[20] E. Antman,et al. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. , 1980, Annals of internal medicine.
[21] E. Antman,et al. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. , 1980, Annals of internal medicine.
[22] E. Braunwald,et al. Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Braunwald,et al. Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Vatner. Correlation between Acute Reductions in Myocardial Blood Flow and Function in Conscious Dogs , 1980, Circulation research.
[25] J. Fleiss,et al. Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.
[26] E. Braunwald,et al. Review: Observations on experimental myocardial ischaemia , 1980 .
[27] L. Décourt,et al. Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion. , 1980, The American journal of cardiology.
[28] J. Lowe,et al. The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.
[29] J. Lowe,et al. Effect of the Calcium Antagonist Verapamil on Necrosis following Temporary Coronary Artery Occlusion in Dogs , 1977, Circulation.
[30] M. Noble,et al. Total and Regional Coronary Blood Flow Measured by Radioactive Microspheres in Conscious and Anesthetized Dogs , 1969, Circulation research.
[31] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.